Cytokinetics Announces Five Presentations Related to Aficamten at the European Society of Cardiology Congress 2024GlobeNewsWire • 05/15/24
Cytokinetics Reveals More From The Study That Boosted Shares 83% In A DayInvestors Business Daily • 05/13/24
Cytokinetics Announces Primary Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 Congress and Published in the New England Journal of MedicineGlobeNewsWire • 05/13/24
Cytokinetics Announces Additional Results From SEQUOIA-HCM Presented in Late Breaking Clinical Trial Session at the European Society of Cardiology Heart Failure 2024 CongressGlobeNewsWire • 05/13/24
Cytokinetics Announces Start of CEDAR-HCM, a Clinical Trial of Aficamten in a Pediatric Population With Symptomatic Obstructive Hypertrophic CardiomyopathyGlobeNewsWire • 05/08/24
Cytokinetics Announces Topline Data From Phase 1 Clinical Study of CK-4021586GlobeNewsWire • 05/08/24
Cytokinetics (CYTK) May Report Negative Earnings: Know the Trend Ahead of Next Week's ReleaseZacks Investment Research • 05/01/24
Cytokinetics to Host Investor Event and Conference Call to Discuss the Primary Results From SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 CongressGlobeNewsWire • 04/29/24
This weight-loss ETF has performed well in its first five months. How does it compare with cheaper alternatives?Market Watch • 04/10/24
Cytokinetics Announces Three Late Breaking Clinical Trial Presentations Relating to SEQUOIA-HCM at the European Society of Cardiology Heart Failure 2024 CongressGlobeNewsWire • 04/10/24
Cytokinetics Presents Additional 48-Week Data From FOREST-HCM, the Open Label Extension Clinical Study of Aficamten, at The American College of Cardiology 73ʳᵈ Annual Scientific SessionGlobeNewsWire • 04/05/24
Cytokinetics to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewsWire • 04/01/24
Cytokinetics Announces Four Upcoming Presentations at the American College of Cardiology 73rd Annual Scientific SessionGlobeNewsWire • 03/25/24